{
    "title": "AstraZeneca ups profit outlook and boosts anti-obesity pipeline",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-12728791/AstraZeneca-ups-annual-outlook-strong-cancer-drugs-demand.html",
    "date": "2023-11-09",
    "keywords": [
        "revenue",
        "company",
        "quarter",
        "campaign",
        "china",
        "growth",
        "profit",
        "government",
        "forecast",
        "demand",
        "share",
        "consensus",
        "percentage",
        "year",
        "deal",
        "weightloss",
        "anticorruption",
        "impact",
        "maggie",
        "fick",
        "cancer",
        "pipeline",
        "market",
        "drug",
        "ceo",
        "soriot",
        "covid",
        "guidance",
        "pill",
        "paragraphs",
        "thursday",
        "antiobesity",
        "analyst",
        "blockbuster",
        "loss",
        "covid19",
        "vaccine",
        "licence",
        "candidate",
        "acceleration",
        "cardiometabolic",
        "obesity",
        "agreement",
        "statement",
        "doubledigit",
        "string",
        "capitalisation",
        "gmt",
        "terence",
        "mcmanus",
        "fund",
        "manager",
        "asset",
        "management",
        "thirdquarter",
        "momentum",
        "line",
        "currency",
        "basis",
        "increase",
        "astrazenecas",
        "drugmaker",
        "launch",
        "july",
        "bribing",
        "equipment",
        "prescribing",
        "astrazeneca",
        "call",
        "announcement",
        "effect",
        "lasting",
        "reporting",
        "london",
        "bengaluru",
        "editing",
        "bhattacharjee",
        "mark",
        "potter"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}